Masimo Corp (NAS:MASI)
$ 135.26 -0.43 (-0.32%) Market Cap: 7.18 Bil Enterprise Value: 7.99 Bil PE Ratio: 92.01 PB Ratio: 5.26 GF Score: 90/100

Masimo Corp at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 07:30PM GMT
Release Date Price: $145.61 (-2.48%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Let's go ahead and get started here as you progress through the afternoon. My name is David Lewis, medical device analyst at Morgan Stanley. It's my pleasure to have this here -- this afternoon, Masimo and 2 members of management, Micah Young, CFO; and Eli Kammerman, VP of IR and Business Development.

We are going to jump right into Q&A, as I've said all week so far. Make sure you go to the Morgan Stanley research disclosure website and check out my research disclosures. There's fun facts on me.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

Micah, I want to start where we let off just a few weeks ago, frankly with the Analyst Day and the LRP. And there's kind of 2 things I spend a vast majority of our time on today talking about is one, sort of the core business and that wasn't the focus of the Analyst Day. The Analyst Day was really about not the core business, everything in the future, and we're going to talk about those, those 2 or those 2 cities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot